Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bubaline alphaherpesvirus 1

ABSTRACT: Complete Genome sequencing of Bubaline herpesvirus 1 by NGS

PROVIDER: PRJNA261869 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR1593950.fastq.gz	Fastqsanger.gz
	SRR1595999.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Human alphaherpesvirus 2

Project description:Human herpesvirus 2 strain 186 genome sequencing project

| PRJNA59587 | ENA

Human alphaherpesvirus 2

Project description:Human herpesvirus 2 overview

| PRJNA69651 | ENA

Human alphaherpesvirus 2

Project description:Human herpesvirus 2 raw sequence reads

| PRJNA280778 | ENA

Bovine alphaherpesvirus 1 isolate:BHV SHJS

Project description:Bovine herpesvirus type 1

| PRJNA855453 | ENA

Human alphaherpesvirus 1 strain RH2

Project description:Whole genome shotgun sequences of human herpesvirus 1 strain RH2

| PRJDB2363 | ENA

Molecular Profiling of Two HPV16+ OPSCC Brain Metastases

Project description:We report a detailed characterization of the HPV16 genome in two brain metastases from OPSCC tumors. The use of a target enrichment strategy followed by next generation sequencing (NGS) provided an effective way to identify viral infection in tumor genome, including internal deletions and insertion sites into the host genome. Applying similar strategies to a larger cohort of HPV+ HNSCC brain metastases could help to identify biomarkers that can predict metastasis and/or identify novel therapeutic options.

2021-02-28 | MSV000086965 | MassIVE

Felid alphaherpesvirus 1

Project description:Complete Genome Sequences of Felid alphaherpesvirus 1strain GD2019

| PRJNA1144180 | ENA

Proteome-wide identification of SAPs in an industrial yeast strain

Project description:Most proteogenomic approaches for mapping single amino acid polymorphisms (SAPs) require construction of a sample-specific database containing protein variants predicted from the next-generation sequencing (NGS) data. We present a new strategy for direct SAP detection without relying on NGS data. Among the 348 putative SAP peptides identified in an industrial yeast strain, 85.6% of SAP sites were validated by genomic sequencing.

2018-04-18 | PXD003101 | Pride

Clinical and molecular delineation of classical-like Ehlers–Danlos syndrome through a comprehensive next-generation sequencing-based screening system

Project description:Classical-like Ehlers–Danlos syndrome (clEDS) is an autosomal recessive disorder caused by complete absence of tenascin-X resulting from biallelic variation in TNXB. Accurate detection of TNXB variants is challenging because of the presence of the pseudogene TNXA, which can undergo non-allelic homologous recombination. Therefore, we designed a genetic screening system that is performed using similar operations to other next-generation sequencing (NGS) panel analyses and can be applied to accurately detect TNXB variants and the recombination of TNXA-derived sequences into TNXB. We also analyzed the levels of serum form of TNX (sTNX) by Western bot and LC/MS/MS. Using this system, we identified biallelic TNXB variants in nine unrelated clEDS patients. This report is the first to apply an NGS-based screening for TNXB variants and represents the third largest cohort of clEDS.

2023-08-09 | PXD043691 | Pride

Detecting gene copy number alterations by comprehensive genomic profiling: a comparative study in a real-world series of FFPE tumor samples

Project description:Copy number alterations (CNAs) play a fundamental role in cancer development and constitute a potential tool for tailored treatments. The CNAs recognition in formalin fixed paraffin embedded (FFPE) material, to date, relies on fluorescence in situ hybridization, but the introduction of large-scale next-generation sequencing (NGS) has dramatically improved their discovery at genome-wide level. The detection of CNAs by NGS in FFPE material is, nonetheless, a complex issue, which still requires validation studies. Herein, the CNAs detection by a widely used NGS assay (Oncomine Comprehensive Assay plus®, OCA+) were evaluated in 14 FFPE samples mirroring diagnostic daily practice and compared to a whole-genome assay. OCA+, a targeted DNA panel, showed lower CNAs detection sensitivity and equal specificity for gains and losses. According to proprietary software pipeline, OCA+ accurately identify gains characterized by CN ≥5,2. A much less robust threshold (CN ≤1.18) was identified that maximized the difference between true and false positive losses. Orthogonal FISH tests validated seven CNAs characterized by CN gain ≥6 or complete loss. Considering the CNAs growing significance in precision medicine, our findings further prompt towards a robust validation of NGS detection in FFPE materials.

2025-02-12 | GSE277695 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data